119 related articles for article (PubMed ID: 7808792)
1. Nm23 protein expression in thyroid neoplasms.
Royds JA; Silcocks PB; Rees RC; Stephenson TJ
Pathologica; 1994 Jun; 86(3):240-3. PubMed ID: 7808792
[TBL] [Abstract][Full Text] [Related]
2. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.
Arai T; Yamashita T; Urano T; Masunaga A; Itoyama S; Itoh K; Shiku H; Sugawara I
Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
4. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
[TBL] [Abstract][Full Text] [Related]
5. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
6. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
8. NM23 protein in neoplastic and nonneoplastic thyroid tissues.
Bertheau P; De La Rosa A; Steeg PS; Merino MJ
Am J Pathol; 1994 Jul; 145(1):26-32. PubMed ID: 8030752
[TBL] [Abstract][Full Text] [Related]
9. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
10. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
Zou M; Shi Y; al-Sedairy S; Farid NR
Br J Cancer; 1993 Aug; 68(2):385-8. PubMed ID: 8394105
[TBL] [Abstract][Full Text] [Related]
11. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
12. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
13. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Suman VJ; Harmsen WS; Ziesmer SC; Roche PC; Podratz KC
Gynecol Oncol; 1997 Aug; 66(2):238-45. PubMed ID: 9264569
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical analysis of nm23 gene product/nucleoside-diphosphate kinase expression in human lung carcinoma].
Jiang Y; He A; Xia S
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Aug; 18(4):209-11, 254. PubMed ID: 8697510
[TBL] [Abstract][Full Text] [Related]
15. [nm23 expression and its correlation with lung metastasis in human salivary adenoid cystic carcinoma].
Shi H; He R; Qiu W
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jan; 32(1):4-6. PubMed ID: 10677933
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
17. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
Royds JA; Cross SS; Silcocks PB; Scholefield JH; Rees RC; Stephenson TJ
J Pathol; 1994 Mar; 172(3):261-6. PubMed ID: 8195929
[TBL] [Abstract][Full Text] [Related]
18. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
19. Nm23 and cathepsin D expression in laryngeal carcinomas.
Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
[TBL] [Abstract][Full Text] [Related]
20. [Significance of nm23 expression in malignant carcinoma of salivary gland].
Jin H; Li J; Chen X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Nov; 32(6):341-3. PubMed ID: 11189305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
